O
27.84
-0.07 (-0.25%)
| Previous Close | 27.91 |
| Open | 27.94 |
| Volume | 1,042,163 |
| Avg. Volume (3M) | 1,848,907 |
| Market Cap | 4,529,655,296 |
| Price / Earnings (TTM) | 22.10 |
| Price / Earnings (Forward) | 16.05 |
| Price / Sales | 0.870 |
| Price / Book | 3.32 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| Profit Margin | 4.12% |
| Operating Margin (TTM) | 5.94% |
| Diluted EPS (TTM) | 1.25 |
| Quarterly Revenue Growth (YOY) | 16.30% |
| Quarterly Earnings Growth (YOY) | 4.40% |
| Total Debt/Equity (MRQ) | 90.53% |
| Current Ratio (MRQ) | 1.54 |
| Operating Cash Flow (TTM) | 384.96 M |
| Levered Free Cash Flow (TTM) | 294.46 M |
| Return on Assets (TTM) | 6.33% |
| Return on Equity (TTM) | 15.38% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Option Care Health, Inc. | Bearish | Bullish |
AIStockmoo Score
0.8
| Analyst Consensus | -0.5 |
| Insider Activity | 1.5 |
| Price Volatility | 2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.80 |
|
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 103.96% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 38.00 (Barrington Research, 36.49%) | Buy |
| Median | 35.50 (27.51%) | |
| Low | 27.00 (TD Cowen, -3.02%) | Hold |
| Average | 34.00 (22.13%) | |
| Total | 3 Buy, 1 Hold | |
| Avg. Price @ Call | 26.56 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| TD Cowen | 03 Nov 2025 | 27.00 (-3.02%) | Hold | 26.42 |
| 02 Oct 2025 | 30.00 (7.76%) | Hold | 27.84 | |
| Barrington Research | 31 Oct 2025 | 38.00 (36.49%) | Buy | 26.03 |
| 23 Sep 2025 | 38.00 (36.49%) | Buy | 27.70 | |
| Citizens | 31 Oct 2025 | 36.00 (29.31%) | Buy | 26.03 |
| Morgan Stanley | 17 Oct 2025 | 35.00 (25.72%) | Buy | 27.77 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KRAEMER HARRY M JANSEN JR | 26.42 | - | 38,000 | 1,003,960 |
| Aggregate Net Quantity | 38,000 | |||
| Aggregate Net Value ($) | 1,003,960 | |||
| Aggregate Avg. Buy ($) | 26.42 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KRAEMER HARRY M JANSEN JR | Director | 03 Nov 2025 | Buy (+) | 38,000 | 26.42 | 1,003,960 |
| Date | Type | Details |
|---|---|---|
| 03 Nov 2025 | Announcement | Option Care Health to Participate in Upcoming Investor Conferences |
| 30 Oct 2025 | Announcement | Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025 |
| 25 Sep 2025 | Announcement | Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call |
| 25 Aug 2025 | Announcement | Option Care Health To Participate in Upcoming Investor Conferences |
| 20 Aug 2025 | Announcement | Option Care Health Announces Chief Financial Officer Transition |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |